Software and Technology Licenses, Net
Bristol-Myers Squibb Software and Technology Licenses, Net decreased by 6.1% to $6.08B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.7%, from $5.87B to $6.08B. Over 5 years (FY 2020 to FY 2025), Software and Technology Licenses, Net shows relatively stable performance with a -1.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests ongoing investment in technology and digital capabilities, which can drive long-term operational efficiency.
Detailed definition
This represents the capitalized cost of acquired software and technology licenses, net of accumulated amortization. It r...
Peer comparison
Increasingly important across the restaurant sector as companies invest in mobile apps, kiosks, and data analytics.
software_technology_licenses_netHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.45B | $7.40B | $5.54B | $4.85B | $4.73B | $4.75B | $4.94B | $4.87B | $5.02B | $5.21B | $5.37B | $6.02B | $6.07B | $6.04B | $6.11B | $5.87B | $5.94B | $6.33B | $6.47B | $6.08B |
| QoQ Change | — | +14.7% | -25.2% | -12.5% | -2.4% | +0.4% | +4.1% | -1.5% | +3.2% | +3.8% | +3.0% | +12.2% | +0.8% | -0.4% | +1.0% | -3.9% | +1.2% | +6.7% | +2.2% | -6.1% |
| YoY Change | — | — | — | — | -26.7% | -35.9% | -10.7% | +0.5% | +6.2% | +9.9% | +8.7% | +23.7% | +20.9% | +15.9% | +13.7% | -2.6% | -2.2% | +4.8% | +6.0% | +3.7% |
Software and Technology Licenses, Net at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's software and technology licenses, net?
- Bristol-Myers Squibb (BMY) reported software and technology licenses, net of $6.08B in Q1 2026.
- How has Bristol-Myers Squibb's software and technology licenses, net changed year-over-year?
- Bristol-Myers Squibb's software and technology licenses, net increased by 3.7% year-over-year, from $5.87B to $6.08B.
- What is the long-term trend for Bristol-Myers Squibb's software and technology licenses, net?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's software and technology licenses, net has grown at a -1.6% compound annual growth rate (CAGR), from $7.02B to $6.47B.
- What does software and technology licenses, net mean?
- The net book value of the company's software and technology licenses.